Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.55
-0.53 (-3.76%)
Mar 12, 2026, 10:25 AM EDT - Market open

Wave Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2021FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '21 Dec '19
Cash & Equivalents
602.07302.08200.35150.56147.16
Cash & Short-Term Investments
602.07302.08200.35150.56147.16
Cash Growth
99.31%50.77%33.07%2.31%-15.82%
Accounts Receivable
1.281.4221.09-20
Other Current Assets
11.4716.8913.941218.32
Total Current Assets
614.81320.39235.37162.56185.48
Net Property, Plant & Equipment
19.862835.7240.6454.47
Other Long-Term Assets
3.823.823.863.844.31
Total Assets
638.5352.21274.95207.01284.25
Accounts Payable
15.716.2612.847.289.07
Accrued Expenses
26.5621.0816.8314.8616.19
Current Portion of Leases
8.367.646.714.963.24
Unearned Revenue
44.4465.97150.0637.189.65
Total Current Liabilities
95.07110.95186.4464.2118.15
Long-Term Leases
9.4117.7725.424.9629.3
Other Long-Term Liabilities
7.86.115.677.4865.19
Total Long-Term Liabilities
17.223.8741.01102.4394.49
Total Liabilities
112.27134.82227.45166.64212.64
Common Stock
1,6161,175935.37749.85539.55
Additional Paid-in Capital
228.37156.45129.2487.9857.28
Accumulated Other Comprehensive Income
-0.25-0.26-0.120.180.27
Retained Earnings
-1,326-1,122-1,025-805.51-533.36
Total Common Shareholders' Equity
518.36209.5239.6332.563.73
Minority Interest
7.877.877.877.877.87
Shareholders' Equity
526.23217.3947.540.3771.61
Total Liabilities & Equity
638.5352.21274.95207.01284.25
Total Debt
17.7725.432.1229.9232.55
Net Cash (Debt)
584.3276.67168.23120.65114.61
Net Cash Growth
111.19%64.46%39.44%5.27%-34.44%
Net Cash Per Share
3.462.001.592.333.38
Book Value
518.36209.5239.6332.563.73
Book Value Per Share
3.071.520.370.631.88
Tangible Book Value
518.36209.5239.6332.563.73
Tangible Book Value Per Share
3.071.520.370.631.88
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q